Essential role of the disulfide-bonded loop of chromogranin B for sorting to secretory granules is revealed by expression of a deletion mutant in the absence of endogenous granin synthesis

Journal of Cell Biology

Volumn 140, Issue 6, 1998, Pages 1331-1346

  Krömer, Andreas ^a,b   Glombik, Michael M ^a   Huttner, Wieland B ^a   Gerdes, Hans Hermann ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Prof Dr Lucker GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN B;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DISULFIDE BOND; GENETIC TRANSFECTION; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FAMILY; PROTEIN TARGETING; RAT; SECRETORY GRANULE;

EID: 0039359126     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.140.6.1331     Document Type: Article

References (65)

1. Arvan, P., and D. Castle. 1992. Protein sorting and secretion granule formation in regulated secretory cells. Trends Cell Biol. 2:327-331.
2. Bablanian, R., M. Esteban, B. Baxt, and J.A. Sonnabend. 1978. Studies on the mechanisms of vaccinia virus cytopathic effects. I. Inhibition of protein synthesis in infected cells is associated with virus-induced RNA synthesis. J. Gen. Virol. 39:391-402.
3. Baeuerle, P.A., and W.B. Huttner. 1987. Tyrosine sulfation is a trans-Golgi-specific protein modification. J. Cell Biol. 105:2655-2664.
4. Bauerfeind, R., R. Jelinek, and W.B. Huttner. 1995. SynaptotagminI- and II-deficient PC12 cells exhibit calcium-independent, depolarization-induced neurotransmitter release from synaptic-like microvesicles. FEBS Lett. 364: 328-334.
5. Benedum, U.M., A. Lamouroux, D.S. Konecki, P. Rosa, A. Hille, P.A. Baeuerle, R. Frank, F. Lottspeich, J. Mallet, and W.B. Huttner. 1987. The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO (Eur. Mol. Biol. Organ.) J. 6:1203-1211.
6. Brion, C., S.G. Miller, and H.-P.H. Moore. 1992. Regulated and constitutive secretion. Differential effects of protein synthesis arrest on transport of glycosaminoglycan chains to the two secretory pathways. J. Biol. Chem. 267: 1477-1483.
7. Burgess, T.L., and R.B. Kelly. 1987. Constitutive and regulated secretion of proteins. Ann. Rev. Cell Biol. 3:243-293.
8. Burgess, T.L., C.S. Craik, L. Matsuuchi, and R.B. Kelly. 1987. In vitro mutagenesis of trypsinogen: role of the amino terminus in intracellular protein targeting to secretory granules. J. Cell Biol. 105:659-668.
9. Castle, A.M., L.E. Stahl, and J.D. Castle. 1992. A 13-amino acid N-terminal domain of a basic proline-rich protein is necessary for storage in secretory granules and facilitates exit from the endoplasmic reliculum. J. Biol. Chem. 267:13093-13100.
10. Chanat, E., and W.B. Huttner. 1991. Milieu-induced, selective aggregation of rceulated secretory proteins in the trans-Golgi network. J. Cell Biol. 115: 1505-1519.
11. Chanat, E., U. Weiß, W.B. Huttner, and S.A. Tooze. 1993. Reduction of the disulfide bond of chromogranin B (secretogranin I) in the trans-Golgi network causes its missorting to the constitutive secretory pathway. EMBO (Eur. Mol. Biol. Organ.) J. 12:2159-2168.
12. Chanat, E., U. Weiß, and W.B. Huttner. 1994. The disulfide bond in chromogranin B, which is essential for its sorting to secretory granules, is not required for its aggregation in the trans-Golgi network. FEBS Lett. 351:225-230.
13. Chevrier, D., H. Fournier, C. Nault, M. Zollinger, P. Crine, and G. Boileau. 1993. Targeting of pro-opiomelanocortin to the regulated secretory pathway may involve cooperation between different protein domains. Mol. Cell. Endocrinol. 94:213-221.
14. Chocran, M.A., C. Puckett, and B. Moss. 1985. In vitro mutagenesis of the promotor region for a vaccinia virus gene: evidence for tandem early and late regulatory signals. J. Virol. 54:30-37.
15. Chu, W.N., J.D. Baxter, and T.L. Reudelhuber. 1990. A targeting sequence for dense secretory granules resides in the active renin protein moiety of human preprorenin. Mol. Endocrinol. 90:1905-1913.
16. Colomer, V., G.A. Kieska, and M.J. Rindler. 1996. Secretory granule content proteins and the luminal domains of granule membrane proteins aggregate in vitro at mildly acidic pH. J. Biol. Chem. 271:48-55.
17. Cool, D.R., and Y. Peng Loh. 1994. Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin. Biochimie (Paris). 76:265-270.
18. Cool, D.R., M. Fenger, C.R. Snell, and Y.P. Loh. 1995. Identification of the sorting signal motif within pro-opiomelanocortin for the regulated secretory pathway. J. Biol. Chem. 270:8723-8729.
19. fat mice. Cell. 88:73-83.
20. Edwards, R.H., M.J. Selby, W.C. Mobley, S.L. Weinrich, D.E. Hruby, and W.J. Rutter. 1988. Processing and secretion of nerve growth factor: expression in mammalian cells with a vaccinia virus vector. Mol. Cell. Biol. 8:2456-2464.
21. Falkner, F.G., and B. Moss. 1988. Escherichia coli gpt gene provides dominant selection for vaccinia virus open reading frame expression vectors. J. Virol. 62:1849-1854.
22. Gerdes, H.-H., and W.B. Huttner. 1995. Chromogranin B. A. Haeberli, editor, VCH Verlagsges. mbH, Weinheim 3rd Installment.
23. Gerdes, H.-H., P. Rosa, E. Phillips, P.A. Baeuerle, R. Frank, P. Argos, and W.B. Huttner. 1989. The primary structure of human secretogranin~1t.*a widespread tyrosine-sulfated secretory granule protein that exhibits low pH- and calcium-induced aggregation. J. Biol. Chem. 264:12009-12015.
24. Gorr, S.-U., J. Shioi, and D.V. Cohn. 1989. Interaction of calcium with porcine adrenal chromogranin A (secretory protein-I) and chromogranin B (secretogranin I). Am. J. Physiol. 257:247-254.
25. Hänggi, M., W. Bannwarth, and H.G. Stunnenberg. 1986. Conserved TAAAT motif in vaccinia virus late promotors: overlapping TATA box and site of transcription initiation. EMBO (Eur. Mol. Biol. Organ.) J. 5:1071-1076.
26. Heumann, R., V. Kachel, and H. Thoenen. 1983. Relationship between NGF-mediated volume increase and "priming effect" in fast and slow reacting clones of PC12 pheochromocytoma cells. Exp. Cell Res. 145:179-190.
27. Hruby, D.E., G. Thomas, E. Herbert, and C.A. Franke. 1986. Use of vaccinia virus as a neuropeptide expression vector. Methods Enzymol. 124:295-309.
28. Huttner, W.B., H.-H. Gerdes, and P. Rosa. 1991. The granin (chromogranin/secretogranin) family. Trends Biochem. Sci. 16:27-30.
29. Iacangelo, A.L., M. Grimes, and L.E. Eiden. 1991. The bovine chromogranin A gene: structural basis for hormone regulation and generation of biologically active peptides. Mol. Endocrinol. 5:1651-1660.
30. Kaether, C., T. Salm, M. Glombik, W. Almers, and H.-H. Gerdes. 1997. Targeting of green fluorescent protein to neuroendocrine secretory granules: a new tool for real time studies of regulated protein secretion. Eur. J. Cell Biol. 74:133-342.
31. Kizer, J.S., and A. Tropsha. 1991. A motif found in propeptides and prohormones that may target them to secretory vesicles. Biochem. Biophys. Res. Commun. 174:586-592.
32. Kuliawat, R., and P. Arvan. 1992. Protein targeting via the "constitutive-like" secretory pathway in isolated pancreatic islets: passive sorting in the immature granule compartment. J. Cell Biol. 118:521-529.
33. 4. Nature. 227:680-685.
34. Lee, R.W., and W.B. Huttner. 1983. Tyrosine-O-sulfated proteins of PC12 pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotransferase. J. Biol. Chem. 258:11326-11334.
35. Leitinger, B., J.L. Brown, and M. Spiess. 1994. Tagging secretory and membrane proteins with a tyrosine sulfation site. J. Biol. Chem. 269:8115-8121.
36. Matsuuchi, L., and R.B. Kelly. 1991. Constitutive and basal secretion from the endocrine cell line. AtT-20. J. Cell Biol. 112:843-852.
37. Moss, B. 1968. Inhibition of HeLa cell protein synthesis by the vaccinia virion. J. Virol. 2:1028-1037.
38. Mouland, A.J., S. Bevan, J.H. White, and G.N. Hendy. 1994. Human chromogranin A Gene. J. Biol. Chem. 269:6918-6926.
39. Natori, S., and W.B. Huttner. 1996. Chromogranin B (secretorgranin I) promotes sorting to the regulated secretory pathway of processing intermediates derived from a peptide hormone precursor. Proc. Natl. Acad. Sci. USA. 93:4431-4436.
40. Owen, M.C., and R.W. Carrell. 1992. Alpha-1-proteinase inhibitor. A. Haeberli, ed., VCH Verlagsges. mbH, Weinheim 1. Installment.
41. Palmer, D.J., and D.L. Christie. 1992. Identification of molecular aggregates containing glycoproteins III. J. K (carboxypeptidase H), and H (Kex2-related proteases) in the soluble and membrane fractions of adrenal medullary chromaffin granules. J. Biol. Chem. 267:19806-19812.
42. Pogo, B.G.T., and S. Dales. 1971. Biogenesis of vaccinia: separation of early stages from maturation by means of hydroxyurea. Virology. 43:144-151.
43. Pohl, T.M., E. Phillips, K. Song, H.-H. Gerdes, W.B. Huttner, and U. Rüther. 1990. The organisation of the mouse chromogranin B (secretoaranin I) gene. FEBS Lett. 262:219-224.
44. Powell, S.K., L. Orci, C.S. Craik, and H.-P.H. Moore. 1988. Efficient targeting to storage granules of human proinsulins with altered propeptide domain. J. Cell Biol. 106:1843-1851.
45. Rosa, P., and H.-H. Gerdes. 1994. The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors. J. Endocrinol. Invest. 17:207-225.
46. Rosa, P., U. Weiß, R. Pepperkok, W. Ansorge, C. Niehrs, E. H. K. Stelzer, and W. B. Huttner. 1989. An antibody against secretogranin I (chromogranin B) is packaged into secretory granules. J. Cell Biol. 109:17-34.
47. Rosa, P., M. Bassetti, U. Weiß, and W.B. Huttner. 1992. Widespread occurrence of chromogranins/secretogranins in the matrix of secretory granules of endocrinologically silent pituitary adenomas. J. Histochem. Cytochem. 40:523-533.
48. Roy, P., D. Chevrier, H. Fournier, C. Racine, M. Zollinger, P. Crine, and G. Boileau. 1991. Investigation of a possible role of the amino-terminal proregion of proopiomelanocortin in its processing and targeting to secretory granules. Mol. Cell. Endocrinol. 82:237-250.
49. Schmelz, M., B. Sodeik, M. Ericcson, E.J. Wolffe, H. Shida, G. Hiller, and G. Griffiths. 1994. Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans golgi network. J. Virol. 68:130-147.
50. Seethaler, G., M. Chaminade, R. Vlasak, M. Ericsson, G. Griffiths, O. Toffoletto, J. Rossier, H.G. Stunnenberg, and G. Kreil. 1991. Targeting of frog prodermorphin to the regulated secretory pathway by fusion to proenkephalin. J. Cell Biol. 114:1125-1133.
51. Sevarino, K.A., and P. Stork. 1991. Multiple preprosomalostatin sorting signals mediate secretion via discrete cAMP- and tetradecanoylphorbolacetate-responsive pathways. J. Biol. Chem. 266:18507-18513.
52. Sevarino, K.A., P. Stork, R. Ventimiglia, G. Mandel, and R.H. Goodman. 1989. Amino-terminal sequences of prosomatostatin direct intracellular targeting but not processing specificity. Cell. 57:11-19.
53. Sodeik, B., R.W. Doms, M. Ericsson, G. Hiller, C.E. Machamer, W. van't Hof, G. van Meer, B. Moss, and G. Griffiths. 1993. Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the golgi stacks. J. Cell Biol. 121:521-541.
54. Stoller, T.J., and D. Shields. 1989. The propeptide of presomatostatin mediates intracellular transport and secretion of α-globin from mammalian cells. J. Cell Biol. 108:1647-1655.
55. Tam, W.W.H., K.I. Andreasson, and Y. Peng Loh. 1993. The amino-terminal sequence of pro-opiomelanocortin directs intracellular targeting to the regulated secretory pathway. Eur. J. Cell Biol. 62:294-306.
56. Thomas, G., E. Herbert, and D.E. Hruby. 1986. Expression and cell type-specific processing of human preproenkephalin with a vaccinia recombinant. Science. 232:1641-1643.
57. Thomas, G., B.A. Thorne, L. Thomas, R.G. Allen, D.E. Hruby, R. Fuller, and J. Thorner. 1988. Yeast KEX2 endopeptidase correctly cleaves a neuroendocrine prohormone in mammalian cells. Science. 241:226-230.
58. Tooze, S.A., and W.B. Huttner. 1990. Cell-free protein sorting to the regulated and constitutive secretory pathways. Cell. 60:837-847.
59. Tooze, S.A., and W.B. Huttner. 1992. Cell-free formation of immature secretory granules and constitutive secretory vesicles from the trans-Golgi network. Methods Enzymol. 219:81-93.
60. Tooze, S.A., T. Flatmark, J. Tooze, and W.B. Huttner. 1991. Characterization of the immature secretory granule, an intermediate in granule biogenesis. J. Cell Biol. 115:1491-1503.
61. Tooze, S.A., E. Chanat, J. Tooze, and W.B. Huttner. 1993. Secretory granule formation. In Mechanisms of Intracellular Trafficking and Processing of Proproteins. Y. Peng Loh, editor. CRC Press, Boca Raton. 157-177.
62. von Brunn, A., K. Früh, H. Stunnenberg, and H. Bujard. 1988. 22 nm-like particles of the hepatitis B surface antigen containing epitopes of p190 of P. falciparum. In Technologicial Advances in Vaccine Development. Alan R. Liss, Inc. 167-173.
63. Wu, H.-J., D.J. Rozansky, R.J. Parmer, B.M. Gill, and D.T. O'Connor. 1991. Structure and function of the chromogranin A gene. J. Biol. Chem. 266: 13130-13134.
64. Yoo, S.H. 1996. pH- and Ca2+-dependent aggregation property of secretory vesicle matrix proteins and the potential role of chromogranins A and B in secretory vesicle biogenesis. J. Biol. Chem. 271:1558-1565.
65. 2+-induced conformational change and aggregation of chromogranin A. J. Biol. Chem. 265:14414-14421.